Manipulation of BDNF causes the overshoot-and-decline effect in DG after the recovery from sleep deprivation
DOI:
https://doi.org/10.61173/1wm7c140Keywords:
Neurogenesis, BDNF/TrkB pathway, Erk5 inhibitorsAbstract
This paper investigates the relationship between the neurogenesis of the dentate gyrus (DG) under sleep deprivation and brain-derived neurotrophic factors (BDNF). The study focuses on DG because it is a critical part of memory formation and is easily affected by neurodegeneration. The paper proposes that BDNF will affect controlling the overshoot and its decline in the period of sleep deprivation and recovery. This study contains two experiments to test this hypothesis. In experiment one, TrkB inhibitors are used to manipulate the amount of BDNF to test its function. In experiment two, Erk5/TrkB inhibitors are used during recovery to test what Bcl2 does to the overshoot. In the future, this finding could potentially be part of the method used to treat neurodegeneration diseases like Alzheimer’s.
References
[1] Amaral, D. G., Scharfman, H. E., & Lavenex, P. (2007). The dentate gyrus: Fundamental neuroanatomical organization (dentate gyrus for dummies). Progress in Brain Research, 163, 3–22. https://doi.org/10.1016/S0079-6123(07)63001-5
[2] Anacker, C., Luna, V. M., Stevens, G. S., Millette, A., Shores, R., Jimenez, J. C., Chen, B., & Hen, R. (2018). Hippocampal neurogenesis confers stress resilience by inhibiting the ventral dentate gyrus. Nature, 559(7712), 98–102. https://doi. org/10.1038/s41586-018-0262-4
[3] Anerillas, C., Herman, A. B., Munk, R., Garrido, A., Lam, K.-W. G., Payea, M. J., Rossi, M., Tsitsipatis, D., Martindale, J. L., Piao, Y., Mazan-Mamczarz, K., Fan, J., Cui, C.-Y., De, S., Abdelmohsen, K., de Cabo, R., & Gorospe, M. (2022). A BDNF- TrkB autocrine loop enhances senescent cell viability. Nature Communications, 13(1), Article 1. https://doi.org/10.1038/ s41467-022-33709-8
[4] Boldrini, M., Fulmore, C. A., Tartt, A. N., Simeon, L. R., Pavlova, I., Poposka, V., Rosoklija, G. B., Stankov, A., Arango, V., Dwork, A. J., Hen, R., & Mann, J. J. (2018). Human Hippocampal Neurogenesis Persists throughout Aging. Cell Stem Cell, 22(4), 589-599.e5. https://doi.org/10.1016/ j.stem.2018.03.015
[5] Brower, M., Grace, M., Kotz, C. M., & Koya, V. (2015). Comparative analysis of growth characteristics of Sprague Dawley rats obtained from different sources. Laboratory Animal Research, 31(4), 166–173. https://doi.org/10.5625/ lar.2015.31.4.166
[6] Federman, N., & McDermott, R. (2019). Larotrectinib is a highly selective tropomyosin receptor kinase (TRK) inhibitor for Dean&Francis the treatment of TRK fusion cancer. Expert Review of Clinical Pharmacology, 12(10), 931–939. https://doi.org/10.1080/175124 33.2019.1661775
[7] Hairston, I. S., Peyron, C., Denning, D. P., Ruby, N. F., Flores, J., Sapolsky, R. M., Heller, H. C., & O’Hara, B. F. (2004). Sleep Deprivation Effects on Growth Factor Expression in Neonatal Rats: A Potential Role for BDNF in the Mediation of Delta Power. Journal of Neurophysiology. https://doi. org/10.1152/jn.00894.2003
[8] Hardwick, J. M., & Soane, L. (2013). Multiple functions of BCL-2 family proteins. Cold Spring Harbor Perspectives in Biology, 5(2), a008722. https://doi.org/10.1101/cshperspect. a008722
[9] Hill, A. S., Sahay, A., & Hen, R. (2015). Increasing Adult Hippocampal Neurogenesis is Sufficient to Reduce Anxiety and Depression-Like Behaviors. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 40(10), 2368–2378. https://doi. org/10.1038/npp.2015.85
[10] Jin, W. (2020). Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson’s Disease. Journal of Clinical Medicine, 9(1), 257. https://doi.org/10.3390/ jcm9010257
[11] Ming, G., & Song, H. (2011). Adult Neurogenesis in the Mammalian Brain: Significant Answers and Significant Questions. Neuron, 70(4), 687–702. https://doi.org/10.1016/ j.neuron.2011.05.001
[12] Mirescu, C., Peters, J. D., Noiman, L., & Gould, E. (2006). Sleep deprivation inhibits adult neurogenesis in the hippocampus by elevating glucocorticoids. Proceedings of the National Academy of Sciences of the United States of America, 103(50), 19170–19175. https://doi.org/10.1073/pnas.0608644103
[13] Morrison, D. K. (2012). MAP kinase pathways. Cold Spring Harbor Perspectives in Biology, 4(11), a011254. https://doi. org/10.1101/cshperspect.a011254
[14] Poon, W. W., Carlos, A. J., Aguilar, B. L., Berchtold, N. C., Kawano, C. K., Zograbyan, V., Yaopruke, T., Shelanski, M., & Cotman, C. W. (2013). β-Amyloid (Aβ) oligomers impair brainderived neurotrophic factor retrograde trafficking by downregulating ubiquitin C-terminal hydrolase, UCH-L1. The Journal of Biological Chemistry, 288(23), 16937–16948. https://doi. org/10.1074/jbc.M113.463711
[15] Sung, P.-S., Lin, P.-Y., Liu, C.-H., Su, H.-C., & Tsai, K.- J. (2020). Neuroinflammation and Neurogenesis in Alzheimer’s Disease and Potential Therapeutic Approaches. International Journal of Molecular Sciences, 21(3), 701. https://doi. org/10.3390/ijms21030701
[16] Wojtowicz, J. M., & Kee, N. (2006). BrdU assay for neurogenesis in rodents. Nature Protocols, 1(3), 1399–1405. https://doi.org/10.1038/nprot.2006.224
[17] Yue, J., & López, J. M. (2020). Understanding MAPK Signaling Pathways in Apoptosis. International Journal of Molecular Sciences, 21(7), 2346. https://doi.org/10.3390/ ijms21072346
[18] Zhang, X., Liu, X., Zhou, D., & Zheng, G. (2020). Targeting anti-apoptotic BCL-2 family proteins for cancer treatment. Future Medicinal Chemistry, 12(7), 563–565. https:// doi.org/10.4155/fmc-2020-0004
Downloads
Published
Issue
Section
License
Copyright (c) 2024 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
